title: [Acute coronary syndrome during oral capecitabine monotherapy].
authors.forename: Vicens
authors.initials: V
authors.lastname: Martí
authors.forename: Joan
authors.initials: J
authors.lastname: Monell
authors.forename: Filipe
authors.initials: F
authors.lastname: Seixo
authors.forename: Carles
authors.initials: C
authors.lastname: Falces
mesh_terms: D054058:Acute Coronary Syndrome / Q000139:chemically induced*; D000284:Administration, Oral; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D000069287:Capecitabine; D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil